N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride
C19H32Cl2N4O3S — CID 119572490
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride
N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride (PubChem CID 119572490) has the molecular formula C19H32Cl2N4O3S and a molecular weight of 467.46 g/mol. Its IUPAC name is N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride.
Molecular Properties
| Compound Name | N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride |
|---|---|
| PubChem CID | 119572490 |
| Molecular Formula | C19H32Cl2N4O3S |
| Molecular Weight | 467.46 g/mol |
| Exact Mass | 466.16 |
| IUPAC Name | N-(1-amino-2-cyclopropylpropan-2-yl)-2-[4-(3-methylphenyl)piperazin-1-yl]sulfonylacetamide;dihydrochloride |
| SMILES | Cc1cccc(N2CCN(S(=O)(=O)CC(=O)NC(C)(CN)C3CC3)CC2)c1.Cl.Cl |
| InChI | InChI=1S/C19H30N4O3S.2ClH/c1-15-4-3-5-17(12-15)22-8-10-23(11-9-22)27(25,26)13-18(24)21-19(2,14-20)16-6-7-16;;/h3-5,12,16H,6-11,13-14,20H2,1-2H3,(H,21,24);2*1H |
| InChIKey | WDALHSJGGVSYON-UHFFFAOYSA-N |
| XLogP | 1.53 |
| TPSA | 95.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 467.46 |
| LogP ≤ 5 | 1.53 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119572490 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.